Net absorption of lab space in the Bay Area turned negative in the first quarter, with 453K SF of occupancy losses, according ...

Writing off CSL entirely may be premature. The post CSL shares halved, can analysts be right about a 100% rebound? appeared ...

Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply ...

Funders and developers of technology to reduce agricultural methane say most farmers will need financial incentives to use them.

Is MEDP a good stock to buy? We came across a bullish thesis on Medpace Holdings, Inc. on The Atomic Moat’s Substack by Rob H ...

Expanding from its core sleep apnoea franchise, Resmed has paid $500 million to treat the common restless leg syndrome.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now. On April 13, ...

Vivek Ramaswamy backed a national COVID registry that would 'segregate' Americans, while his biotech firm got $2.25B from ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

Discover how an equity market neutral strategy balances long and short positions to hedge market exposure and achieve ...

See more on Vaxcyte's (PCVX) and VAX-31’s broad pneumococcal vaccine pipeline, strong cash runway, and key 2026–2027 trial ...

The Blue Buck antelope disappeared from Earth more than 200 years ago. Now, Colossal Biosciences says it can bring it back.